印度广告标准委员会（ASCI）周三表示，该自律机构评估的所有营养保健品广告均存在虚假宣传。
All s of the nutraceutical sector assessed by the Advertising Standards Council of India were found to be peddling fake claims, the self-regulatory body said on Wednesday.
声明称，该机构在今年7月至9月期间评估了61则广告，已完成对其中60个广告活动的处理。“所有处理完毕的60则广告均被认定违反ASCI准则，”官方声明说。
The body said it evaluated 61 ads between July and September this year, and has finished processing for 60 such campaigns.“All 60 ads where processing is complete were found in violation of the ASCI Code,” an official statement said.
在已处理的广告中，29则未被品牌方提出异议。其余31则提出异议的广告中，品牌方的抗辩均未能为其宣称提供充分依据。
Among the processed ads, 29 were not contested by the brands at all. For the remaining 31 that were contested, the objections failed to provide adequate substantiation for the claims made in their s.Key violations related to claims around weight management, anti-ageing, skin lightening, UV protection and respiratory health, ASCI said.
ASCI表示，主要违规涉及体重管理、抗衰老、美白、紫外线防护和呼吸健康等方面的宣称。报告还指出，部分广告宣称可解决哮喘、慢阻肺、高血压、高胆固醇和多囊卵巢综合征等疾病，强调夸大疗效和误导性画面会制造不切实际的预期，模糊一般健康辅助与医疗手段的界限。
ASCI秘书长兼首席执行官Manisha Kapoor表示：“随着该品类增长，广告宣称的力度必须与现有证据相匹配，以便消费者做出明智决定，避免因超出证据范围的承诺而破坏信任。”
The report also flagged s claiming to address conditions such as asthma, COPD, blood pressure, cholesterol and PCOS, highlighting how exaggerated outcomes and misleading visuals can create unrealistic expectations and blur the distinction between general wellness support and medical treatment.“As the category grows, it is important that the strength of advertising claims matches the evidence available, so consumers can make informed decisions, and trust is not compromised by promises that go beyond proof,” ASCI’s secretary general and chief executive Manisha Kapoor said.
引用一份研究报告，ASCI称营养保健品行业2025年估值达387.7亿美元。
Citing a research report, ASCI said that the nutraceutical sector was valued at $38.77 billion in 2025.